IRIS
MAGNI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.829
AS - Asia 11.833
EU - Europa 10.375
SA - Sud America 1.770
Continente sconosciuto - Info sul continente non disponibili 604
AF - Africa 395
OC - Oceania 30
Totale 44.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.050
CN - Cina 5.763
SG - Singapore 2.594
IE - Irlanda 2.253
IT - Italia 1.689
BR - Brasile 1.341
RU - Federazione Russa 1.235
HK - Hong Kong 1.117
DE - Germania 1.070
VN - Vietnam 1.052
UA - Ucraina 991
FI - Finlandia 895
FR - Francia 634
GB - Regno Unito 516
SE - Svezia 457
CA - Canada 351
IN - India 318
ZA - Sudafrica 213
AR - Argentina 166
BD - Bangladesh 146
MX - Messico 135
IQ - Iraq 111
BE - Belgio 107
JP - Giappone 107
NL - Olanda 93
PL - Polonia 89
ES - Italia 83
EC - Ecuador 71
TR - Turchia 71
CO - Colombia 65
PK - Pakistan 58
IL - Israele 52
AT - Austria 50
IR - Iran 45
ID - Indonesia 44
VE - Venezuela 43
CR - Costa Rica 42
MA - Marocco 38
UZ - Uzbekistan 38
SA - Arabia Saudita 37
CH - Svizzera 36
CW - ???statistics.table.value.countryCode.CW??? 34
MY - Malesia 33
CL - Cile 32
CZ - Repubblica Ceca 32
GT - Guatemala 32
TT - Trinidad e Tobago 31
PH - Filippine 30
SV - El Salvador 29
HN - Honduras 27
SC - Seychelles 27
JM - Giamaica 26
JO - Giordania 26
PR - Porto Rico 25
GP - Guadalupe 24
LT - Lituania 24
NI - Nicaragua 24
EU - Europa 22
AU - Australia 21
NP - Nepal 20
AE - Emirati Arabi Uniti 18
GR - Grecia 18
TN - Tunisia 18
AZ - Azerbaigian 17
EG - Egitto 17
KZ - Kazakistan 17
ET - Etiopia 16
PE - Perù 16
DO - Repubblica Dominicana 14
RO - Romania 14
BO - Bolivia 13
KE - Kenya 13
KR - Corea 13
DZ - Algeria 12
LV - Lettonia 12
TH - Thailandia 12
AL - Albania 11
UY - Uruguay 11
PY - Paraguay 10
AM - Armenia 9
PS - Palestinian Territory 9
QA - Qatar 9
HR - Croazia 8
LB - Libano 8
OM - Oman 8
KG - Kirghizistan 7
LK - Sri Lanka 7
NZ - Nuova Zelanda 7
PT - Portogallo 7
BG - Bulgaria 6
HU - Ungheria 6
SN - Senegal 6
BB - Barbados 5
BY - Bielorussia 5
GE - Georgia 5
KW - Kuwait 5
NG - Nigeria 5
RS - Serbia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
Totale 44.192
Salva come PNG Salva come JPEG
Città #
Dublin 2.248
Chandler 2.067
Ashburn 1.931
San Jose 1.759
Dallas 1.491
Singapore 1.467
Jacksonville 1.309
Nanjing 1.147
Hong Kong 1.079
Beijing 1.017
Boardman 814
Council Bluffs 791
Nanchang 482
Los Angeles 451
Ho Chi Minh City 383
New York 378
Princeton 367
Lauterbourg 363
Pavia 362
Lawrence 354
Wilmington 351
Ann Arbor 326
Changsha 326
Helsinki 313
Shenyang 310
Hebei 309
Dearborn 304
Medford 304
Hanoi 262
Shanghai 255
Milan 250
Moscow 249
Jiaxing 245
Munich 218
Tianjin 196
Hangzhou 190
Johannesburg 180
Buffalo 179
Redondo Beach 163
São Paulo 157
Santa Clara 147
Toronto 125
Orem 123
Brussels 99
Turku 99
Rome 98
Tokyo 96
Woodbridge 87
Seattle 83
Atlanta 78
Brooklyn 78
Montreal 74
Norwalk 71
Warsaw 71
Chennai 70
Frankfurt am Main 69
Chicago 68
London 66
Verona 65
Phoenix 64
Denver 62
Florence 55
Guangzhou 55
Houston 52
Piscataway 52
San Francisco 51
Kunming 49
Mexico City 49
Da Nang 47
Falkenstein 45
Nuremberg 45
Stockholm 45
Boston 44
Jinan 43
Washington 43
Amsterdam 41
Newark 39
Haiphong 38
Poplar 35
Tashkent 35
Baghdad 34
Columbus 34
Mumbai 34
Ningbo 34
Zhengzhou 34
Fairfield 33
Rio de Janeiro 33
Willemstad 33
Manchester 31
Naples 31
San José 31
Brasília 30
Des Moines 29
Turin 29
Quito 26
Vienna 26
Dhaka 25
Hefei 25
San Salvador 25
Basingstoke 24
Totale 28.604
Salva come PNG Salva come JPEG
Nome #
A comparison of eVai, CADD and VVP variant prediction results on the ICR639 hereditary cancer dataset 232
An automatic implementation of ACMG/ClinGen guidelines for constitutional Copy Number Variants annotation and interpretation 225
Living Materials for the Detection of Volatile Compounds to Monitor Agroindustrial Processes 210
Quantitative evaluation of RC-106 antitumor activity in GBM spheroids through tumor growth inhibition modeling based on cell counts data 196
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 196
A Bayesian approach to non-parametric AUC estimation in population studies 195
Analysis of amplicon-based NGS data from neurological disease gene panels: a new method for allele drop-out management 191
A Bayesian method for clustering gene expression temporal profiles from microarray data 190
A Markov decision process: screening hereditary hemochromatosis 180
Astrazioni temporali per il clustering di profili di espressione genica 180
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 174
Phenotypes extraction from clinical descriptions using Large Language Models 171
A non parametric population approach for selecting biomarkers of a drug action 169
DIVAs: a phenotype-based machine-learning model to assess the pathogenicity of digenic variant combinations 168
A Perl procedure for the analysis of phosphopeptide tandem mass spectra 167
OPTIMIZATION OF GAMMA-PGA BIOSYNTHESIS SUPPORTED BY SYNTHETIC BIOLOGY AND METABOLIC ENGINEERING STRATEGIES 164
Improving protein identification by MsPI using peak intensity 163
Phosphopeptide identification: an automated Perl procedure 163
An integrative pathology workflow to enhance molecular diagnostics in precision oncology 162
A Perl procedure to improve the efficiency of the identification and characterization of phosphopeptides 161
In-Silico and in-Vivo Metabolic Engineering Strategies to Optimize Waste Bioconversion Pathways in Microbial Strains: Two Case Studies on Ethanol and Poly-Gamma-Glutamic Acid Biosynthesis 158
A procedure to decompose high resolution mass spectra 157
Clinical classification of myelofibrosis with myeloid metaplasia (MMM): cluster analysis of 861 patients enrolled into a nationwide prospective registry (RIMM) 156
A Bayesian nonparametric approach to AUC determination in population studies 156
Ethanol? Whey not! 155
Methods for the analysis of mass spectrometry data in proteomics 155
A data mining approach to evaluate the performance of recruitment centres in antidepressant drug clinical trials 154
A standard vector for the chromosomal integration and characterization of BioBrick™ parts in Escherichia coli 154
A BioBrick-compatible Vector for Allelic Replacement Using the XylE Gene as Selection Marker 154
A tumor growth inhibition model in drugs combination regimens 153
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 153
A Bioinformatics Approach to Explore MicroRNAs as Tools to Bridge Pathways Between Plants and Animals. Is DNA Damage Response (DDR) a Potential Target Process? 153
Integrative analysis of heterogeneous high-throughput transcriptomic data for promoter selection in bacterial genomes to support microbial synthetic biology 152
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 151
Integration of enzymatic data in Bacillus subtilis genome-scale metabolic model improves phenotype predictions and enables in silico design of poly-γ-glutamic acid production strains 151
Bottom-up engineering of biological systems through standard bricks: a modularity study on basic parts and devices 150
A bioinformatic approach to predict the cross-kingdompotential of plant miRNA in humans 150
A mathematical model to study the effects of drugs administration on tumor growth dynamics 150
Protein identification by peptide mass fingerprinting: a perl procedure 149
A mathematical model for assessing the glucose time course in critically ill patients 149
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 148
Evaluation of the T-IDDM Project in Pavia 148
Analysis of intergenic conserved sequences in the POF critical region on X chromosome 144
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time 144
Precedence Temporal Networks: a New Tool for Extracting Temporal Relationships in Gene Expression Profiles 143
Characterization of a synthetic bacterial self-destruction device for programmed cell death and for recombinant proteins release 143
'Indolent' myelofibrosis with myeloid metaplasia: specific clinical features and prognosis 143
Evaluation of software tools for Bayesian estimation on population models:an update based on current software versions 142
CRISPR Interference Modules as Low-Burden Logic Inverters in Synthetic Circuits 142
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 141
Learning Gene Regulatory Networks with an Intelligent Data Analysis Approach: An Application to the Yeast Cell Cycle 141
Movement detection from a wearable system: a deconvolution-based approach 141
Precedence Temporal Networks from Gene Expression Data 140
A Perl procedure for protein identification by Peptide Mass Fingerprinting 140
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 140
A methodology for the reliable analysis of amplicon-based NGS data 140
Methods and tools for multiscale modelling in Systems Pharmacology: a review 139
Engineering endogenous fermentative routes in ethanologenic Escherichia coli W for bioethanol production from concentrated whey permeate 139
Bottom-up design of genetic circuits: characterization and re-use of biological building blocks to engineer predictable systems 138
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 138
Genome-wide gene expression in aneurysmal aortic walls of patients with Marfan Syndrome (MFS) and Loeys-Dietz Syndromes (LDS) with known causative mutations 138
A PK/PD model for tumor-in-host growth kinetics following administration of an antiangiogenic agent given alone or in combination regimens 138
Precedence Temporal Networks: Extraction and Representation of Temporal Relationships in Gene Expression Profiles 137
Protein identification by MsPI software tool: implementation of a scoring function intensity-based 137
Analisi di dati di DNA microarray: reti di regolazione 137
Characterization of regulatory parts for the metabolic engineering of E. coli and B. subtilis: applications in the conversion of bio-waste into biofuels and bioproducts 137
Optimization of γ-PGA biosynthesis supported by synthetic biology and metabolic engineering strategies 137
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 136
Biologia sintetica e standardizzazione: verso la programmazione razionale di funzioni biologiche artificiali 136
Optimal age and strategy for screening hereditary hemochromatosis. The answers from a Markov decision process 135
Learning Rules with Complex Temporal Patterns in Biomedical Domains 135
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 135
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 135
Three thiamine analogues differently alter thiamine transport and metabolism in nervous tissues: an in vivo kinetic study using rats 135
PREDICTIVE METHOD FOR DETERMINING THE PATHOGENICITY OF COMBINATIONS OF DIGENIC OR OLIGOGENIC VARIANTS 134
Clustering bayesiano di serie temporali di espressione genica 134
Conversion of industrial bio-waste into biofuels through Syntetic Biology supported by flow cytometry 133
Characterization of promoter strength varying the DNA copy number from one to hundreds of copy 133
Critical assessment of variant prioritization methods for rare disease diagnosis within the rare genomes project 132
Leveraging Two-Stage delta Global Sensitivity Analysis method to inform parameter estimation in PBPK models 132
Heart rate correction of the QT interval: a nonparametric individualized approach 132
Automatic translation of Bayesian pharmacometric models: the PharmML-to-WinBugs converter 132
Modeling myelosuppression in patients treated with anticancer drugs 131
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 131
Design and implementation of a negative feedback controller in E. coli with a bottom-up approach 131
Efficient conversion of industrial bio-waste into biofuels and bioproducts through E. coli and B. subtilis synthetic biology 131
Statistical methods to detect immune responses to drug administration 130
A Synthetic Close-Loop Controller Circuit for the Regulation of an Extracellular Molecule by Engineered Bacteria 130
Predicting Aqueous and Intrinsic Solubility of Pharmaceutical Molecules with Neural Networks 130
Characterization of a synthetic luxR-HSL repressible promoter for the design of novel activation-repression circuits in E. coli 129
Improving Phosphopeptides Identification by MS/MS Spectra Analysis: A NewPerl Software Tool 129
Artificial intelligence and machine learning: just a hype or a new opportunity for pharmacometrics? 129
Characterization of promoter strength at different DNA copy numbers using RPU approach 128
Online Microreactor Titanium Dioxide RPLC-LTQ-Orbitrap MS Automated Platform for Shotgun Analysis of (Phospho) Proteins in Human Amniotic Fluid 128
Mathematical modeling of growth and death dynamics of mouse embryonic stem cells irradiated with gamma-rays 128
Evaluation of software tools for Bayesian estimation on population models with count and continuous data 128
Dealing with stochasticity in precision dosing decision-making processes by fully exploiting PK-PD modelling in Reinforcement Learning algorithms. A practical case-study on Vancomycin continuous infusion in ICU patients 127
BioBrick, standard assembly e registro delle parti biologiche standard 127
Methods for genetic optimization of biocatalysts for biofuel production from dairy waste through synthetic biology 127
Accurate peak list extraction from proteomic mass spectra for identification and profiling studies 127
Totale 14.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.610 0 0 0 0 23 39 52 126 95 48 297 930
2022/20235.952 651 527 83 416 567 520 17 328 2.564 36 137 106
2023/20242.397 227 459 106 163 169 505 133 171 31 64 115 254
2024/20256.165 122 590 193 202 219 225 260 412 1.536 198 707 1.501
2025/202614.935 1.263 1.168 1.866 1.775 1.959 664 2.563 553 1.227 1.043 419 435
2026/20274.043 216 692 842 1.467 826 0 0 0 0 0 0 0
Totale 44.836